# Anika Therapeutics, Inc.: Form 8-K, filed Jun 23, 2026

- Company: [Anika Therapeutics, Inc.](/companies/anik.md) (CIK 898437)
- Form: 8-K
- Filed: 2026-06-23
- Accepted by EDGAR: Jun 23, 2026, 16:05 ET
- Period: 2026-06-18
- Accession: 0001171843-26-004253
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/898437/000117184326004253/f8k_062326.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/898437/000117184326004253/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/898437/000117184326004253/f8k_062326.htm

Filed Jun 23, 2026.
Source: SEC EDGAR, the filing index for accession 0001171843-26-004253. Last ingested by Listed: Nov 6, 2026, 15:05 ET. No prices; not investment advice.